'en:cep regimen'
(id=7141810 ; fe=en:cep regimen ; type=1 ; niveau=200 ;
luminosité=25 ;
somme entrante=410 creation date=2017-06-25 touchdate=2025-04-26 20:15:40.000) ≈ 7 relations sortantes
- en:cep regimen --
r_associated #0: 40 / 1 ->
en:antineoplastic combined chemotherapy protocols
n1=en:cep regimen | n2=en:antineoplastic combined chemotherapy protocols | rel=r_associated | relid=0 | w=40
- en:cep regimen --
r_associated #0: 31 / 0.775 ->
en:cyclophosphamide
n1=en:cep regimen | n2=en:cyclophosphamide | rel=r_associated | relid=0 | w=31
- en:cep regimen --
r_associated #0: 29 / 0.725 ->
en:epirubicin
n1=en:cep regimen | n2=en:epirubicin | rel=r_associated | relid=0 | w=29
- en:cep regimen --
r_associated #0: 28 / 0.7 ->
en:procarbazine
n1=en:cep regimen | n2=en:procarbazine | rel=r_associated | relid=0 | w=28
- en:cep regimen --
r_associated #0: 20 / 0.5 ->
cyclophosphamide
n1=en:cep regimen | n2=cyclophosphamide | rel=r_associated | relid=0 | w=20
- en:cep regimen --
r_associated #0: 20 / 0.5 ->
procarbazine
n1=en:cep regimen | n2=procarbazine | rel=r_associated | relid=0 | w=20
- en:cep regimen --
r_associated #0: 2 / 0.05 ->
en:therapeutic or preventive procedure
n1=en:cep regimen | n2=en:therapeutic or preventive procedure | rel=r_associated | relid=0 | w=2
| ≈ 14 relations entrantes
- procarbazine ---
r_associated #0: 85 -->
en:cep regimen
n1=procarbazine | n2=en:cep regimen | rel=r_associated | relid=0 | w=85
- en:procarbazine ---
r_associated #0: 83 -->
en:cep regimen
n1=en:procarbazine | n2=en:cep regimen | rel=r_associated | relid=0 | w=83
- cyclophosphamide ---
r_associated #0: 66 -->
en:cep regimen
n1=cyclophosphamide | n2=en:cep regimen | rel=r_associated | relid=0 | w=66
- en:cyclophosphamide ---
r_associated #0: 64 -->
en:cep regimen
n1=en:cyclophosphamide | n2=en:cep regimen | rel=r_associated | relid=0 | w=64
- en:antineoplastic combined chemotherapy protocols ---
r_associated #0: 20 -->
en:cep regimen
n1=en:antineoplastic combined chemotherapy protocols | n2=en:cep regimen | rel=r_associated | relid=0 | w=20
- en:epirubicin ---
r_associated #0: 20 -->
en:cep regimen
n1=en:epirubicin | n2=en:cep regimen | rel=r_associated | relid=0 | w=20
- cyclope (oeil) ---
r_associated #0: 15 -->
en:cep regimen
n1=cyclope (oeil) | n2=en:cep regimen | rel=r_associated | relid=0 | w=15
- Cyclophosphamide ---
r_associated #0: 10 -->
en:cep regimen
n1=Cyclophosphamide | n2=en:cep regimen | rel=r_associated | relid=0 | w=10
- Procarbazine ---
r_associated #0: 10 -->
en:cep regimen
n1=Procarbazine | n2=en:cep regimen | rel=r_associated | relid=0 | w=10
- en:cyclops eye ---
r_associated #0: 10 -->
en:cep regimen
n1=en:cyclops eye | n2=en:cep regimen | rel=r_associated | relid=0 | w=10
- épirubicine ---
r_associated #0: 10 -->
en:cep regimen
n1=épirubicine | n2=en:cep regimen | rel=r_associated | relid=0 | w=10
- cyclopeptide ---
r_associated #0: 5 -->
en:cep regimen
n1=cyclopeptide | n2=en:cep regimen | rel=r_associated | relid=0 | w=5
- cyclophiline ---
r_associated #0: 5 -->
en:cep regimen
n1=cyclophiline | n2=en:cep regimen | rel=r_associated | relid=0 | w=5
- cyclophorie ---
r_associated #0: 5 -->
en:cep regimen
n1=cyclophorie | n2=en:cep regimen | rel=r_associated | relid=0 | w=5
|